Companies that are hoping for better fortune were responsible for many of the major jumps in the junior market this week. Who said it was a quiet week?
Simec Atlantis Energy has seen its stock tumble 98% in the last five years. This week, it made waves when it was awarded a contract by the UK government to provide tidal energy in Scotland. It claimed that it will be the largest of its kind anywhere in the world.
Market Summary > @simecatlantis
LON #SAE
1.90 GBX+0.65 (51.43%)⤴️today
7 Jul, 13:08 BST • Disclaimer
Successfully secured a Contract for Difference in the latest allocation round, for the world-leading MeyGen site. The CfD, guarantees £178.54 (£/MWh) https://t.co/nQ395hSVgp https://t.co/2spJbxWTIg— Share_Talk ™ (@Share_Talk) July 7, 2022
It was one of four tidal projects to win backing in the latest ‘contracts-for-difference’ auction from the UK Department for Business, Energy and Industrial Strategy, where each will be guaranteed a price floor and stable prices for their output for at least a decade.
The company won Simec’s MeyGen Tidal Project, giving it a path to develop the entire 400-megawatt array. This has been in development for over a decade. Shares rose 59% to 1.98p.
Chief executive Graham Reid stated that today’s announcement is important and cannot be undervalued.
Eurasia Mining came alive this week, recovering 36.94% of its share value over the past five days, Zak Mir was instrumental in highlighting the company three times this week on his Bulletin Board Heros charting blog.
Nanosynth was even more impressive, and its plans to create an antiviral facial mask during the pandemic got investors excited under its old name Remote Monitored Systems.
Its shares rose 1500% from less than one penny to nearly 5p in late 2020, but it fell back to earth after delays and the elimination of mask rules.
Market Summary > Nanosynth Group PLC
LON #NNN
0.41 GBX+0.19 (82.89%)⤴️today
4 Jul, 11:38 BST • Disclaimerpic.twitter.com/z1CKr5f55y https://t.co/u0KOAF6X2v— Share_Talk ™ (@Share_Talk) July 4, 2022
The shares have risen 96.40% to 0.49p this week after the company refocused its focus on nanotechnology last summer. This was based on a Monday update when the share price was at 0.25p.
It also mentioned an “exciting pipeline” of interest in its spray-on copper nanomaterials to improve the antiviral properties of medical masks and other filters. The company is currently preparing an application with UK Health and Safety Executive.
Another development is the creation of an e-commerce subsidiary, which will be the “largest producer of nanomaterials” in the market. There are also reports that talks are ongoing over possible partnerships for 37 of its business research and development projects.
https://twitter.com/Share_Talk/status/1545433302512828422?s=20&t=_p5nn5ly5gHrJWJPzof1ew
Another rising star was Tekmar. After sinking to over 96% since the outbreak of the pandemics, it bounced 174.59% on Friday at 16.45. It did this after bagging a significant new contract’ of unknown size for an offshore Japanese wind farm project. A record order book of £20.1m was announced with the first-half results
EQTEC rose 25% to 0.75p in another part of the green energy market after it entered the liquid fuels market with a framework agreement. This agreement allowed them to work together on waste-to-fuel projects with CompactGTL, a gas-to-liquids specialist.
They plan to develop, build, and operate waste-to-fuel projects as well as other energy infrastructure and synthetic fuel projects. The initial focus will be on small-scale modular waste-to-fuel plants.
Deepverge climbed 23% to 12.27p after it announced that its consumer offering, Skin Trust Club has generated more than £1million in revenue.
This year, 20 new sales and marketing deals were made with companies that support’ Labskin technology for products.
Filtronic saw a 15% jump to 14p following the award of a contract to design and produce a series of filter-related developments for an existing aerospace and defense customer.
However, gains like these were offset by nearly as many losses throughout the week. The AIM All-Share Index was only marginally higher than flat at 880.28. This was slightly better than the 31-point drop for the FTSE 100.
Bluerock Diamonds was the biggest loser, dropping 42% to 7.5p. After a refinancing that could result in existing shareholders being heavily diluted, Bluerock Diamonds lost some of its sparkles.
It has signed a £1million loan agreement with Teichmann Co. This will be converted to equity at 7p per share and increase Teichmann’s stake to 51%. However, a waiver must be requested from the Takeover Panel to ensure that Teichmann does not have to make a binding offer.
@_BlueRock lost its shine after a refinancing that could see existing shareholders greatly diluted. It signed a £1m note with Teichmann Company Limited. This will be converted into equity at 7p per share, taking Teichmann's stake to 51% from 17.4% #BRD https://t.co/BJgY5Rxgju pic.twitter.com/YHYdHhYMeB
— Share_Talk ™ (@Share_Talk) July 5, 2022
Mike Houston, executive chairman, stated that the need for financing was a result of the prolonged and excessively wet season this year. This has delayed the production ramp-up and the development of our main pit. This has led to lower production levels and lower grades than anticipated.
A profit warning by Supreme which distributes lightbulbs and batteries, caused its shares to drop 36.2% to 79.88p.
The company, which was floated in February of last year, also stated that it was reducing its dividend payout ratio to make more investments in the business, including potential mergers and acquisitions.
It warned that there was a marked slowdown in lightbulbs, light fittings and other lightbulbs in the last year. Guidance for the next year has also been trimmed.
Novacyt was one of the top small-cap stars for 2020. It fell 32% to 108.72p following a hard hit by Covid-19-related business.
According to the specialist in clinical diagnostics, the first half of revenue suffered a 73% drop in pandemic-related sales compared with the same period last year. This was faster than the company had expected.
It stated that full-year revenues will be approximately £20million lower than originally expected if the rate of sales decline continues in the second quarter.
Novacyt stated that it will discontinue Microgen Bioproducts and Lab21 Healthcare businesses, and is working to reduce its costs.
After announcing that its first-half revenue growth was below forecasts, the sports nutrition company Science in Sport dropped 30% to 31p on Friday.
According to the company, it expects a loss in margins for the year because of higher prices and closing its Russian operations. First-half revenue growth will be lower than expected.
